Researcher biography

I am a globally recognised leader in harm reduction research on image and performance enhancing drugs (IPEDs), with over $7.5 million in funding and >140 publications. I have just been awarded a highly competitive NHMRC Investigator Fellowship to examine how both individual behaviours and systemic factors, such as stigma and healthcare barriers, shape the risk profiles of steroid consumers. As a nationally recognised peer researcher and Vice President of the Queensland Injectors Voice for Advocacy and Action (QuIVAA), I bring a unique combination of lived experience and academic expertise to this work.

My award-winning research program triangulates insights from IPED consumers and health professionals to address critical policy and service gaps. This has led to pioneering initiatives such as the world's first steroid drug checking trial, which was awarded Harm Reduction Program of the Year (AIVL, 2024). I also founded Steroid QNECT, Australia's only peer-led steroid education program, now informing national harm reduction strategies. I have received the AIVL Peer Researcher Recognition Award (2024) and the APSAD Kyp Kypri Early Career Researcher Award 2024 for exceptional performance relative to opportunity. My work delivers innovative, evidence-based interventions that inform policy and improve outcomes for people who use IPEDs.